George S. Golumbeski's most recent trade in Sage Therapeutics Inc was a trade of 21,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Mural Oncology plc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,637 | 8,637 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 13,593 | 13,593 | - | - | Stock Options (Right to buy) | |
| Mural Oncology plc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 15,334 | 15,334 | - | - | Stock Option (right to buy) |